| Value | ₹9.46 Cr |
|---|
BSE filing, NSE: SRF. Summary written from the filing by ALFA Finder's alert engine.
SRF Ltd: key numbers
- Share price
- ₹2,409.00
- Market cap
- ₹71,409 Cr
- Revenue (annual)
- ₹15,787 Cr
- Net profit (annual)
- ₹1,835 Cr
- P/E (TTM)
- 31.3×Sector 33.6×
- Promoter holding
- 50.26%+0.00% QoQ
- FII holding
- 15.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from SRF Ltd
All →SRF Earnings Call Transcript: Key Takeaways
SRF delivered robust revenue growth driven by chemical segment recovery and packaging films stability. Management remains optimistic about H2 FY27 performance despite global geopolitical and logistics headwinds.
- Call
- Guides 20% growth
SRF Investor Presentation: Key Takeaways
SRF reported strong Q2FY27 performance with revenue at ₹4,904.2 Cr, driven by high growth in Chemicals and Performance Films. Strategic shift continues toward high-value battery foil and sunrise sectors.
SRF Results Update
SRF Ltd reported Q2 FY27 revenue ₹4,904 Cr (+35% YoY) and PAT ₹509 Cr. Board approved ₹600 Cr for a 12,000 MTA aluminium foil plant.
- battery-grade aluminium foil manufacturing capacity
- 12000 MTA
SRF Capacity Expansion: ₹600 Cr Investment
SRF's Board approved a Rs.600 Crore project at Jetapur for aluminium foil for battery applications. The 12,000 MTPA capacity will be added in two phases by 2030.
- Value
- ₹600.0 Cr
- Execution
- Two phases: by 30 Sep 2028 (Phase I) and by 30 Sep 2030 (Phase II)
- aluminium foil production capacity
- 12000 MTPA
SRF Q2 FY27 Results: Net Profit ₹509.1 Cr, Up 31.1% YoY
SRF Ltd reported revenue from operations of ₹4,904 Cr (+34.7% YoY) and net profit of ₹509.1 Cr (+31.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹509.1 Cr · +31.1% YoY
SRF Other Announcement
SRF Limited submitted its quarterly Shareholding Pattern for the period ending September 30, 2026, as required under SEBI Regulation 31.
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.